We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
-0.35%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$1.59B
AUM Growth
+$469M
Cap. Flow
+$491M
Cap. Flow %
30.91%
Top 10 Hldgs %
26.26%
Holding
2,828
New
215
Increased
1,024
Reduced
629
Closed
413
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGHT icon
2276
Sight Sciences
SGHT
$291M
$630 ﹤0.01%
173
LZ icon
2277
LegalZoom.com
LZ
$1.38B
$624 ﹤0.01%
83
-104
-56% -$783
NUVB icon
2278
Nuvation Bio
NUVB
$2.24B
$623 ﹤0.01%
234
CATY icon
2279
Cathay General Bancorp
CATY
$4.27B
$619 ﹤0.01%
13
TPH
2280
DELISTED
Tri Pointe Homes
TPH
$617 ﹤0.01%
17
+3
+21% +$125
ALRS icon
2281
Alerus Financial
ALRS
$849M
$616 ﹤0.01%
32
-32
-50% -$703
ENOV icon
2282
Enovis
ENOV
$1.75B
$615 ﹤0.01%
+14
New +$615
FWRG icon
2283
First Watch Restaurant Group
FWRG
$792M
$615 ﹤0.01%
33
+14
+74% +$247
AKRO
2284
DELISTED
Akero Therapeutics
AKRO
$613 ﹤0.01%
+22
New +$666
NEWT icon
2285
NewtekOne
NEWT
$441M
$613 ﹤0.01%
48
-37
-44% -$502
OPRX icon
2286
OptimizeRx
OPRX
$127M
$613 ﹤0.01%
+126
New +$704
TNDM icon
2287
Tandem Diabetes Care
TNDM
$1.33B
$613 ﹤0.01%
17
-9
-35% -$304
MTX icon
2288
Minerals Technologies
MTX
$2.38B
$610 ﹤0.01%
8
-226
-97% -$17.8K
BVS icon
2289
Bioventus
BVS
$1.03B
$609 ﹤0.01%
+58
New +$686
OLN icon
2290
Olin
OLN
$2.13B
$609 ﹤0.01%
18
-1,226
-99% -$51.2K
TRML
2291
DELISTED
Tourmaline Bio
TRML
$609 ﹤0.01%
+30
New +$755
UIS icon
2292
Unisys
UIS
$214M
$608 ﹤0.01%
+96
New +$669
MUR icon
2293
Murphy Oil
MUR
$5.34B
$606 ﹤0.01%
20
-265
-93% -$8.52K
PLRX icon
2294
Pliant Therapeutics
PLRX
$65M
$606 ﹤0.01%
+46
New +$628
QTRX icon
2295
Quanterix
QTRX
$174M
$606 ﹤0.01%
57
+44
+338% +$535
VIAV icon
2296
Viavi Solutions
VIAV
$9.84B
$606 ﹤0.01%
60
TGTX icon
2297
TG Therapeutics
TGTX
$7.5B
$602 ﹤0.01%
+20
New +$574
ARDX icon
2298
Ardelyx
ARDX
$1.21B
$599 ﹤0.01%
+118
New +$652
COMB icon
2299
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
$145M
$599 ﹤0.01%
30
SPIB icon
2300
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$595 ﹤0.01%
+18
New +$596

Similar funds

Arax Advisory Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Arax Advisory Partners held 2,828 positions worth $1.59B, up 42% from $1.12B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Arax Advisory Partners deployed $491M of net new capital in Q4 2024, opening 215 new positions and adding to 1,024 existing holdings. Its largest new stake was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Mid-Cap Value ETF, an estimated $3.07M trimmed.

  • Arax Advisory Partners's largest Q4 2024 buy was First Trust Low Duration Strategic Focus ETF: 643,026 shares worth $12.1M.
  • Arax Advisory Partners added most to Vanguard Morningstar Growth ETF in Q4 2024, an estimated $33.3M increase.
  • Arax Advisory Partners's biggest Q4 2024 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $3.07M.
  • Arax Advisory Partners fully exited WillScot Mobile Mini Holdings in Q4 2024, selling an estimated $508K.
  • Arax Advisory Partners's ten largest holdings make up 26% of its $1.59B portfolio in Q4 2024.
  • Arax Advisory Partners opened 215 new positions and closed 413 in Q4 2024.
  • Arax Advisory Partners's portfolio value rose 42% quarter-over-quarter to $1.59B.

Based on Arax Advisory Partners's 13F filing for Q4 2024, filed 5 Feb 2025.